Alberta Investment Management Corp (AIMCo)’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,325
Closed -$453K 1108
2023
Q2
$453K Sell
5,325
-1,496
-22% -$126K ﹤0.01% 969
2023
Q1
$564K Buy
+6,821
New +$552K 0.01% 935
2019
Q1
Sell
-11,200
Closed -$1.12M 927
2018
Q4
$1.12M Buy
+11,200
New +$1.18M 0.01% 523

Other funds holding HAE

Alberta Investment Management Corp (AIMCo)'s HAE Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Haemonetics (HAE) in Q3 2023, closing a stake of 5,325 shares — an estimated $453K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HAE in Q4 2018 and held it in 3 quarters. The position peaked at $1.12M in Q4 2018. 296 funds tracked by Wall St. Rank hold HAE as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Haemonetics position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 5,325 Haemonetics shares in Q3 2023, an estimated $453K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Haemonetics in Q4 2018 and held it in 3 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Haemonetics position peaked at $1.12M in Q4 2018.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.